295 related articles for article (PubMed ID: 27109610)
21. Astragaloside IV prevents kidney injury caused by iatrogenic hyperinsulinemia in a streptozotocin‑induced diabetic rat model.
He KQ; Li WZ; Chai XQ; Yin YY; Jiang Y; Li WP
Int J Mol Med; 2018 Feb; 41(2):1078-1088. PubMed ID: 29207011
[TBL] [Abstract][Full Text] [Related]
22. [NFAT2 mediates high glucose-induced apoptosis in glomerular podocytes
He C; Shi W; Li R; Zhang L
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1270-1276. PubMed ID: 30377135
[TBL] [Abstract][Full Text] [Related]
23. Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway.
Zhang S; Wang H; Liu Y; Yang W; Liu J; Han Y; Liu Y; Liu F; Sun L; Xiao L
J Cell Mol Med; 2020 Sep; 24(17):9810-9824. PubMed ID: 32779844
[TBL] [Abstract][Full Text] [Related]
24. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
[TBL] [Abstract][Full Text] [Related]
25. Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo.
Gui D; Guo Y; Wang F; Liu W; Chen J; Chen Y; Huang J; Wang N
PLoS One; 2012; 7(6):e39824. PubMed ID: 22745830
[TBL] [Abstract][Full Text] [Related]
26. Phosphodiesterase 5 inhibition ameliorates angiontensin II-induced podocyte dysmotility via the protein kinase G-mediated downregulation of TRPC6 activity.
Hall G; Rowell J; Farinelli F; Gbadegesin RA; Lavin P; Wu G; Homstad A; Malone A; Lindsey T; Jiang R; Spurney R; Tomaselli GF; Kass DA; Winn MP
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1442-50. PubMed ID: 24740790
[TBL] [Abstract][Full Text] [Related]
27. Astragaloside IV improves high glucose-induced podocyte adhesion dysfunction via alpha3beta1 integrin upregulation and integrin-linked kinase inhibition.
Chen J; Gui D; Chen Y; Mou L; Liu Y; Huang J
Biochem Pharmacol; 2008 Sep; 76(6):796-804. PubMed ID: 18652804
[TBL] [Abstract][Full Text] [Related]
28. Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy.
Yao X; Guo H; Sun M; Meng S; Zhu B; Fang J; Huang J; Wang H; Xing L
J Diabetes Res; 2022; 2022():1329380. PubMed ID: 35480629
[TBL] [Abstract][Full Text] [Related]
29. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
[TBL] [Abstract][Full Text] [Related]
30. Renal tubular Bim mediates the tubule-podocyte crosstalk via NFAT2 to induce podocyte cytoskeletal dysfunction.
Xu C; Zhou X; Xie T; Zhou Y; Zhang Q; Jiang S; Zhang R; Liao L; Dong J
Theranostics; 2020; 10(15):6806-6824. PubMed ID: 32550905
[TBL] [Abstract][Full Text] [Related]
31. TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-kappaB translocation.
Zhang H; Ding J; Fan Q; Liu S
Exp Biol Med (Maywood); 2009 Sep; 234(9):1029-36. PubMed ID: 19546355
[TBL] [Abstract][Full Text] [Related]
32. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
[No Abstract] [Full Text] [Related]
33. Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling.
Yu J; Zhu C; Yin J; Yu D; Wan F; Tang X; Jiang X
Drug Des Devel Ther; 2020; 14():361-370. PubMed ID: 32095070
[TBL] [Abstract][Full Text] [Related]
34. Effect of astragaloside IV against rat myocardial cell apoptosis induced by oxidative stress via mitochondrial ATP-sensitive potassium channels.
Guan FY; Yang SJ; Liu J; Yang SR
Mol Med Rep; 2015 Jul; 12(1):371-6. PubMed ID: 25739067
[TBL] [Abstract][Full Text] [Related]
35. Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy.
Guo H; Wang Y; Zhang X; Zang Y; Zhang Y; Wang L; Wang H; Wang Y; Cao A; Peng W
Sci Rep; 2017 Jul; 7(1):6852. PubMed ID: 28761152
[TBL] [Abstract][Full Text] [Related]
36. Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes.
Ma R; Xu Y; Zhou H; Zhang D; Yao D; Song L; Liu Y
Mol Med Rep; 2019 Mar; 19(3):2421-2430. PubMed ID: 30664212
[TBL] [Abstract][Full Text] [Related]
37. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
Zhang X; Song Z; Guo Y; Zhou M
Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II Type I Receptor Agonistic Autoantibody Induces Podocyte Injury via Activation of the TRPC6- Calcium/Calcineurin Pathway in Pre-Eclampsia.
Yu Y; Zhang L; Xu G; Wu Z; Li Q; Gu Y; Niu J
Kidney Blood Press Res; 2018; 43(5):1666-1676. PubMed ID: 30380548
[TBL] [Abstract][Full Text] [Related]
39. MDM2 is implicated in high-glucose-induced podocyte mitotic catastrophe via Notch1 signalling.
Tang H; Lei CT; Ye C; Gao P; Wan C; Chen S; He FF; Wang YM; Su H; Zhang C
J Cell Mol Med; 2017 Dec; 21(12):3435-3444. PubMed ID: 28643424
[TBL] [Abstract][Full Text] [Related]
40. Synaptopodin Limits TRPC6 Podocyte Surface Expression and Attenuates Proteinuria.
Yu H; Kistler A; Faridi MH; Meyer JO; Tryniszewska B; Mehta D; Yue L; Dryer S; Reiser J
J Am Soc Nephrol; 2016 Nov; 27(11):3308-3319. PubMed ID: 27020855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]